Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open-label extension to study 49653/461, to assess the long-term safety of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's Disease
rosiglitazone
AVA104617
NCT00381238
Alzheimer's Disease
Phase 2
 
This is a follow-up study to 49653/461.
September 2013

Powered by ideaPoint, Inc.